The estimated Net Worth of E Thomas Corcoran is at least $561 Mille dollars as of 4 September 2024. Mr. Corcoran owns over 5,000 units of Phibro Animal Health stock worth over $511,250 and over the last 11 years he sold PAHC stock worth over $0. In addition, he makes $50,000 as Independent Director at Phibro Animal Health.
E has made over 5 trades of the Phibro Animal Health stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of PAHC stock worth $100,100 on 4 September 2024.
The largest trade he's ever made was buying 5,000 units of Phibro Animal Health stock on 4 September 2024 worth over $100,100. On average, E trades about 5,000 units every 758 days since 2014. As of 4 September 2024 he still owns at least 25,000 units of Phibro Animal Health stock.
You can see the complete history of Mr. Corcoran stock trades at the bottom of the page.
E. Thomas Corcoran serves as Independent Director of the Company. Mr. Corcoran has been a director since May 2008. Mr. Corcoran also serves as Chairman of the Audit Committee. Mr. Corcoran joined Fort Dodge Animal Health, a division of Wyeth, Inc., as its President in 1985. Wyeth was a research-based corporation with businesses focused on human health and animal health. Mr. Corcoran served on the Management, the Operations, the Legal, and the Human Resources and Benefits committees of Wyeth until his retirement in March 2008. From 2010 until 2016, Mr. Corcoran was a director of Putney, Inc., a pet pharmaceutical company. Mr. Corcoran also served as the Chairman of the Animal Health Institute, an industry organization advocating for animal health issues, including efficient and effective FDA, USDA and EPA regulatory and approval processes. Mr. Corcoran serves on the Board of Trustees of the University of South Alabama. Mr. Corcoran is a recipient of the Animal Pharm Lifetime Achievement Award, the Banfield Industry Leadership Award, the Lifetime Achievement Award from the American Veterinary Distributors Association and the Industry Leadership Award from the Kansas City Animal Health Corridor. Mr. Corcoran is a recipient of the Distinguished Alumni Award from the University of South Alabama. Mr. Corcoran is qualified to serve on our Board of Directors due to his extensive experience and executive leadership in the animal health industry.
As the Independent Director of Phibro Animal Health, the total compensation of E Corcoran at Phibro Animal Health is $50,000. There are 13 executives at Phibro Animal Health getting paid more, with Richard Johnson having the highest compensation of $6,293,240.
E Corcoran is 73, he's been the Independent Director of Phibro Animal Health since 2008. There are 2 older and 19 younger executives at Phibro Animal Health. The oldest executive at Phibro Animal Health Corp. is Gerald Carlson, 77, who is the Independent Director.
E's mailing address filed with the SEC is 300 FRANK W. BURR BLVD., STE. 21, , TEANECK, NJ, 07666.
Over the last 11 years, insiders at Phibro Animal Health have traded over $195,476,671 worth of Phibro Animal Health stock and bought 26,000 units worth $514,940 . The most active insiders traders include L.P. Mayflower, Co., Llc Bfi e Jack Bendheim. On average, Phibro Animal Health executives and independent directors trade stock every 17 days with the average trade being worth of $962,991. The most recent stock trade was executed by E Thomas Corcoran on 4 September 2024, trading 5,000 units of PAHC stock currently worth $100,100.
phibro animal health corporation is a leading global diversified animal health and mineral nutrition company. we are dedicated to helping meet the growing demand for animal protein. we concentrate exclusively on animals for food production and are one of the few global companies offering a comprehensive range of animal health and mineral nutrition products. for over 40 years we have been committed to providing livestock producers with value-based products and solutions to help them maintain and enhance the health of their animals. we develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. our products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. phibro animal health corporation reported net sales of $764 million for the fiscal year ended june 30, 2017. our more than 1,400 employees are proud to manufacture and market our
Phibro Animal Health executives and other stock owners filed with the SEC include: